FDA Inspection 1202960 — Societa Italiana Medicinali Scandicci, S.I.M.S. Srl
The FDA completed an inspection of Societa Italiana Medicinali Scandicci, S.I.M.S. Srl on Apr 29, 2022 in Reggello. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 29, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Reggello (Italy)
Additional Details
Mutual Recognition Agreement (MRA)